In addition, although the role of SHBG in the development of breast cancer is complex and may play different roles according to the immunohistochemical phenotype of the ER [20], observational data have shown that circulating SHBG concentration correlates negatively with the risk of postmenopausal breast cancer, especially ER-positive breast cancer [23]. This evidence concerns the gene ESR1 and breast cancer.